InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

- Current share price for CBL : $0.060

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Notification regarding unquoted securities - CBL 7 Sep 2026 3:59PM $0.058 $0.060 risen by 3.45%
$33 Change of Director's Interest Notice - Rix 1 Sep 2026 2:42PM $0.061 $0.060 fallen by 1.64%
$33 2026 Results Commentary 28 Aug 2026 9:17AM $0.060 $0.060 fallen by 0%
$33 Appendix 4G 28 Aug 2026 9:05AM $0.060 $0.060 fallen by 0%
$33 Corporate Governance Statement 28 Aug 2026 9:04AM $0.060 $0.060 fallen by 0%
$33 2026 Annual Report 28 Aug 2026 9:04AM $0.060 $0.060 fallen by 0%
$33 Preliminary Final Report 28 Aug 2026 9:02AM $0.060 $0.060 fallen by 0%
$33 FY26 Results Investor Webcast Notification 27 Aug 2026 2:09PM $0.061 $0.060 fallen by 0.83%
$33 Medicare Billing Code Secured for NextLevel Speech Devices 27 Aug 2026 7:59AM $0.061 $0.060 fallen by 1.64%
$33 NeuroStrip secures MHRA registration 25 Aug 2026 9:49AM $0.058 $0.060 risen by 3.45%
$33 Notification regarding unquoted securities - CBL 12 Aug 2026 10:52AM $0.062 $0.060 fallen by 3.23%
$33 Change in substantial holding - Nightingale 12 Aug 2026 10:49AM $0.064 $0.060 fallen by 6.25%
$33 Change in substantial holding - Phoenix 12 Aug 2026 10:33AM $0.064 $0.060 fallen by 6.25%
$33 Change of Director's Interest Notice - Steele 12 Aug 2026 10:01AM $0.064 $0.060 fallen by 6.25%
$33 Change of Director's Interest Notice - Opie 12 Aug 2026 10:00AM $0.062 $0.060 fallen by 3.23%
$33 Change of Director's Interest Notice - Heard 12 Aug 2026 9:56AM $0.062 $0.060 fallen by 3.23%
$33 Change of Director's Interest Notice - Lismore 12 Aug 2026 9:55AM $0.062 $0.060 fallen by 3.23%
$33 Change of Director's Interest Notice - Rix 12 Aug 2026 9:50AM $0.062 $0.060 fallen by 3.23%
$33 Cleansing notice 12 Aug 2026 9:50AM $0.062 $0.060 fallen by 3.23%
$33 Application for quotation of securities - CBL 12 Aug 2026 9:45AM $0.062 $0.060 fallen by 3.23%
$33 NeuroStrip App Launch on Apple and Microsoft Stores 12 Aug 2026 8:49AM $0.062 $0.060 fallen by 3.23%
$33 Notification regarding unquoted securities - CBL 11 Aug 2026 1:11PM $0.064 $0.060 fallen by 6.25%
$33 Results of Meeting 6 Aug 2026 12:04PM $0.069 $0.060 fallen by 13.04%
$33 US FDA Registration and Device Listing for NeuroStrip 4 Aug 2026 8:26AM $0.065 $0.060 fallen by 7.69%
$33 Commercial momentum builds across both platform pillars 31 Jul 2026 9:10AM $0.066 $0.060 fallen by 9.09%

1 - 25 of 626 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.